Skip to content
OpenCapital
Get started

OS Therapies OSTX Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions

Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Discount For Postvesting Restrictions at other companies

OS Therapies logo
OS TherapiesOSTX
4.1%—
SUI
Sui Group Holdings Limited Common StockSUIG
$0.68—
Corvex logo
Corvex MOVE
4%-0.2pp
Norwood Financial logo
Norwood FinancialNWFL
4.1%-0.3pp
ROC
Rank One Computing ROC
$1.35+141%
Magyar Bancorp logo
Magyar BancorpMGYR
3.3%0.0pp

Other financials

Income statement

See full
Operating income-$10.2M-103%
Net income-$10.4M-168%
EPS (diluted)-$0.27-50.0%

Balance sheet

See full
Cash & equivalents$917.6K-69.1%
Total debt$20.0M—
Total equity-$10.8M-159%
Total assets$7.3M+71.7%

Cash flow

See full
Operating cash flow-$4.6M-32.6%
CapEx$316.4K—
Free cash flow-$3.7M—

Valuation

See full
Market cap$84.62M+65.5%
Enterprise value$103.7M—

Returns & leverage

See full
Return on equity470%—
Debt / equity-1.8×—
Current ratio0.1×-1.1×

Where this comes from

Reported directly by OS Therapies in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsDiscountForPostvestingRestrictions.

The official record: OS Therapies’s 10-Q, filed November 14, 2025, on SEC EDGAR. View the filing →

Ask your AI about OS Therapies's share based compensation arrangement by share based payment award fair value assumptions discount for postvesting restrictions.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is OS Therapies's share based compensation arrangement by share based payment award fair value assumptions discount for postvesting restrictions?
OS Therapies (OSTX) reported share based compensation arrangement by share based payment award fair value assumptions discount for postvesting restrictions of 4.1% in Q2 2025.
What does share based compensation arrangement by share based payment award fair value assumptions discount for postvesting restrictions mean?
Reflects the valuation adjustments applied to share-based payment awards to account for restrictions that persist after the vesting period. This metric is critical for understanding the true economic cost of equity-based incentives and their impact on shareholder dilution.